【4523】エーザイ : EISAI ANNOUNCES RESULTS OF PHASE 3 STUDY OF ANTICANCER AGENT FARLETUZUMAB IN PATIENTS WITH RELAPSED PLATINUM-SENSITIVE OVARIAN CANCER

EISAI ANNOUNCES RESULTS OF PHASE 3 STUDY OF ANTICANCER AGENT FARLETUZUMAB IN PATIENTS WITH RELAPSED PLATINUM-SENSITIVE OVARIAN CANCER

出所:株経通信(株式会社みんかぶ)
PDFをダウンロード